Market Size & Growth Forecasts The global GLP-1 analogues market is estimated at $66.48 billion in 2025, projected to skyrocket to $879.9 billion by 2034, representing an impressive CAGR of ~33.2% Another source estimates the broader GLP-1 market at $47.74 billion in 2024, with a more conservative CAGR of 10.9% from 20252034
Diabetes Complications 31 , 218222 (2017)
Over 104 weeks of treatment, semaglutide produced average weight loss of 15.2%
The combination of traditional and holistic methods equips individuals with tools to cope with lifes challenges beyond treatment
however, weight, Hb, Cr, ALT, fasting glucose, HDL-C, and thyroid stimulating hormone were positively correlated (Supplemental Table S5)
Not for human or animal consumption, and not for medical, therapeutic, or diagnostic use